HORIBA Scientific Introduces New CLUE Series Detectors for Scanning Electron Microscopes
CLUE Series offers scalable platform for imaging and spectroscopic analysis of nano-objects with SEM and dual SEM/FIB (Focused Ion Beam) microscopes.
CLUE Series offers scalable platform for imaging and spectroscopic analysis of nano-objects with SEM and dual SEM/FIB (Focused Ion Beam) microscopes.
Dr. Stephen Chanock, National Cancer Institute, shares the latest cancer epidemiology studies at the NIH and the team’s hopes of being able to predict and prevent disease
Automated microscopy platform offers high flexibility and throughput
High demand for Molecular Biology System's new technology has been predicted across all life science markets
Dr. Aaron Overland from Essen BioScience answers all your webinar questions about quantitative live-cell analysis of neurons
Discover how this game-changing instrument will impact the field and hear about the challenges in developing the next generation of automation technology
3D samples of bone grown from human mesenchymal stem cells without typical osteoinductive media
Naser Jasim discusses his work, his inspiration and his scientific hero
Discover the application notes, scientific posters and compendiums being downloaded daily by clinical scientists
Learn about best practices for immune monitoring assays using xMAP® Technology from Luminex
Prof. Dr. Ger Rijkers tells SelectScience how he is using Luminex xMAP Technology® to develop a multiplex assay that can identify specific antibodies to multiple serotypes of S. pneumoniae in a single test
Registration is now open for our interactive webinar which will present the key benefits and applications of single-cell sequencing
Glythera gains exclusive access to Cancer Research UK’s novel CDK11 inhibitor programme for the development of antibody drug conjugates
Screening for C. Difficile will reduce number of avoidable deaths, writes guest editor Gosia Leitch, Global Product Director with Alere
Dendritic cells are a key contributor to developing cancer vaccines
New CRISPR screening services substantially broaden range of possible genetic studies